Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting

Executive Summary

• Ocumetics’ leadership will meet with potential strategic partners at the ASCRS Annual Meeting to discuss early first‑in‑human (FIH) results of its accommodating intraocular lens.
• The company presented initial surgical outcomes and patient responses from Group 1 procedures and outlined plans for Group 2 surgeries to expand clinical data.
• These engagements are intended to accelerate regulatory approval pathways and commercialization efforts for the Ocumetics Lens.

Key Details

• Meeting Venue & Audience: Washington, D.C., during the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting; attendees include ophthalmic strategic partners and industry stakeholders.
• Clinical Program Status: Ongoing FIH study – Group 1 surgeries completed, providing early insights into surgical performance and patient outcomes.
• Group 2 Surgeries: Planned next phase of enrollment to further evaluate lens performance, consistency, and generate additional data for regulatory and commercial strategy.
• Technology Highlight: Ocumetics Lens is an accommodating intraocular lens designed to fit within the natural lens compartment, enabling dynamic focus shift without glasses or contacts.
• Strategic Objective: Use conference discussions to secure collaborations that will support further clinical development, regulatory approval, and global commercialization.
• CEO Quote: Dean Burns emphasized the value of Group 1 learnings and the importance of partner engagement ahead of the next clinical phase.

Notable Quotes

“Group 1 surgeries provided valuable insights into both surgical performance and patient outcomes of the Ocumetics Lens. Our meetings at ASCRS will allow us to share these learnings directly with potential strategic partners as we prepare for the next phase of the clinical program, including Group 2 surgeries.” – Dean Burns, President & CEO

All boilerplate, forward‑looking disclaimer, and contact information have been omitted per guidelines.